Tg Therapeutics Inc (TGTX)

R&D Expense Growth

96.99%

Quarterly · Period ending:

TGTX logo

TGTX R&D Expense Growth

Latest reported96.99%
TGTX Quarterly R&D Growth (QoQ) (0.00% → 96.99%)
High-resolution chart · PNG

TGTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-100%
113.907%
-453.6066%
192.9882%
94.5504%
0%
-100%
-50%
-33.3333%
-45.4545%
120%
-28.5714%
-12.5%
0%
60%
-54.5455%
450%
-50%
33.3333%
50%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.